Barry J. Simon sold $1.7M of ImmunityBio (IBRX)

Executed Feb 23, disclosed Feb 24, 1 day later.

Value, as filed

$1.7M

165,000 sh × $10.25

Executed

Feb 23

the trade date, as filed

Disclosed

Feb 24

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BS Barry J. Simon Director profile →

Barry J. Simon (Director) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in ImmunityBio, Inc. (IBRX). The largest single filing was $1.7M of IBRX (165,000 sh × $10.25, as filed), executed Feb 23.

The name

IBRX ImmunityBio, Inc. IBRX · Healthcare · 10 filings in 24 months ticker →

Healthcare · ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Barry J. Simon in IBRX

IBRXSALE ImmunityBio, Inc. $197K
25,000 sh × $7.88
Exec Jun 24
Filed Jun 26 · 5:30 PM ET IBRXSALE ImmunityBio, Inc. $165K
23,033 sh × $7.18
Exec Jun 4
Filed Jun 5 · 5:30 PM ET IBRXSALE ImmunityBio, Inc. $901K
75,000 sh × $12.01
Exec Feb 24
Filed Feb 26 · 5:30 PM ET IBRXSALE ImmunityBio, Inc. $1.1M
151,967 sh across 2 lots
Exec Jan 20
Filed Jan 21 · 5:30 PM ET